申请人:Burgdorf Lars Thore
                            
                            
                                公开号:US20090131506A1
                            
                            
                                公开(公告)日:2009-05-21
                            
                            The present invention relates to oxindoles of the formula I, their use as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases and their use for the manufacture of a pharmaceutical composition.